A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.
Researchers gather real world treatment data on psoriatic arthritis patients
Researchers have surveyed 137 respondents from a psoriatic arthritis (PsA) registry for phenotypic features and characteristics, initial and current therapies, and medication preference.
Hepatitis C linked to increased risk for chronic inflammatory skin diseases, study shows
According to a new study, hepatitis C virus (HCV) infection is linked to an increased risk for chronic inflammatory skin diseases (CISDs). The study showed a decreased risk for CISD when treated with interferon-based antiviral therapy.
Study suggests biologics are safe in patients with inflammatory skin disease during pandemic
A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.
Researchers target skin protein that may be linked to severity of psoriasis
New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.
New research suggests bias in studies detailing risk of Covid-19 in psoriasis and psoriatic arthritis patients
A recent systematic evaluation of studies on the risk of Covid-19 in patients with psoriasis and psoriatic arthritis has suggested a high risk of bias. Specifically, papers linking respiratory infection in psoriasis and psoriatic arthritis patients treated with biological therapies.
